Human Mutation News Today

10.11.2022 - - Topline data from Phase 1/2 clinical trial of INZ-701 in ENPP1 Deficiency on track for the fourth quarter of 2022 – - Topline data from Phase 1/2 clinical trial of INZ-701 in ABCC6 Deficiency on track for the first quarter of 2023 – ...

Ann Arbor, Michigan (PRWEB) October 31, 2022 -- Genomenon, Inc., an AI-driven genomics company, announced the publication of a paper in Human Mutation

/PRNewswire/ -- GeneDx, Inc., a leader in genomic analysis, today announced newly published research demonstrating the value of data sharing and research...

/PRNewswire/ -- GeneDx, Inc., a leader in genomic analysis, today announced newly published research demonstrating the value of data sharing and research...